OrthoPediatrics Corp. provided revenue guidance for the fourth quarter and full year ended December 31, 2017. The company announced that preliminary unaudited fourth quarter revenue is expected to be in the range of $11.5 million to $11.7 million, up 22% to 24%, when compared to $9.4 million in the fourth quarter of 2016. The preliminary unaudited full year 2017 revenue is expected to be in the range of $45.4 million to $45.6 million, representing annual growth of 22%.